Acm Research, INC

ACM Research, Inc. successfully concluded its 2026 Annual Meeting of Stockholders with the re-election of all director nominees and the ratification of its independent auditor.

ACM Research (Shanghai) has approved a plan to issue H-shares and list on the Main Board of the Hong Kong Stock Exchange.

ACM Research (Shanghai) reported a 65% year-over-year increase in new orders for Q1 2026 and highlighted technological advancements in high-temperature SPM tools.

ACM Research, Inc. has successfully closed a registered direct offering of 2.88 million shares, raising approximately $149.8 million in net proceeds.

ACM Research, Inc. announced a registered direct offering to sell approximately $150 million of its Class A common stock to U.S. institutional investors.

ACM Research announced robust first-quarter 2026 financial results, with revenue up 34% year-over-year, and maintained its full-year revenue guidance.

ACM Research reported a 34.2% increase in Q1 2026 revenue to $231.3 million, driven by a surge in electrochemical plating and furnace technology sales.

ACM Research, Inc. reported a 32% increase in third-quarter revenue to $269.16 million, driven by strong growth across all product categories, despite a notable decline in gross margin and operating income.

ACM Research reports increased revenue and net income for Q2 2025, driven by strong demand in single wafer cleaning and ECP technologies.

ACM Research's Q1 2025 results show revenue growth driven by single wafer cleaning equipment sales, but gross margin declined due to product mix and inventory provisions.

ACM Research reports a significant increase in revenue and net income for the third quarter of 2024, driven by strong demand for its semiconductor manufacturing equipment.

ACM Research reports a significant increase in revenue and profitability for the second quarter of 2024, driven by strong demand for its semiconductor manufacturing equipment.

ACM Research's 2024 10-K filing reveals revenue growth driven by strong demand in mainland China, balanced against regulatory headwinds and supply chain complexities.

ACM Research outlines its capital structure, voting rights, and compliance with U.S. and Chinese regulations in its annual 10-K filing.

David H. Wang, CEO and Director of ACM Research, Inc., reported the grant of 6,208 Restricted Stock Units (RSUs) on May 13, 2026.

Sotheara Cheav, Senior VP of Manufacturing for ACM Research's Shanghai subsidiary, exercised options and sold 18,750 shares under a pre-arranged trading plan.

ACM Research CEO David H. Wang exercised 100,002 stock options and sold a portion of the resulting shares under a pre-established 10b5-1 trading plan.

ACM Research Director Haiping Dun reported transactions involving Class A Common Stock, including the acquisition of 5,000 shares and the sale of 7,500 shares under a pre-arranged trading plan.

ACM Research Director Charles Pappis exercised options and sold 5,000 shares of Class A Common Stock under a 10b5-1 plan.

ACM Research's CFO and Treasurer, Mark McKechnie, exercised stock options and subsequently sold a portion of the acquired shares under a pre-arranged 10b5-1 trading plan.

ACM Research, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, with key proposals including director elections and auditor ratification.

ACM Research, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.

ACM Research will hold its annual stockholder meeting virtually on June 12, 2025, to vote on the election of directors and the ratification of the independent auditor.

ACM Research, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.

ACM Research will hold its 2024 Annual Meeting of Stockholders virtually on June 13, 2024, to vote on director elections, auditor ratification, and executive compensation.

Vanguard Portfolio Management has reported a 5.31% stake in ACM Research Inc., holding over 3.4 million shares.

The Vanguard Group has filed an amendment to its Schedule 13G for ACM Research Inc., reporting 0% beneficial ownership following an internal realignment.

The Vanguard Group has filed an amendment to its Schedule 13G, reporting an 8.3% beneficial ownership in ACM Research Inc. common stock as of December 31, 2025.

BlackRock, Inc. has disclosed an increased beneficial ownership of 12.6% in ACM Research, Inc.'s Class A Stock, totaling 7,420,308 shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.6% beneficial ownership stake in ACM Research, Inc.'s Class A Stock as of March 31, 2025.